ArticleJournal of Cancer2026

Targeting MUC16 to Reverse Anoikis Resistance: A Promising Strategy for Metastatic Lung Adenocarcinoma Therapy.

Kulsoom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.